In vivo percutaneous penetration/absorption. Sponsored by the American Association of Pharmaceutical Scientist, U.S. Food and Drug Administration, American Academy of Dermatology, Skin Pharmacology Society and the U.S. Army Environmental Hygiene Agency May 1-3, 1989, Washington, DC

Vinod P. Snah, Gordon L. Flynn, Richard H. Guy, Howard I. Maibach, Hans Schaefer, Jerome P. Skelly, Ronald C. Wester, Avraham Yacobi, Bradley D. Anderson, Klaus E. Andersen, Brian W. Barry, Charan R. Behl, Leslie Z. Benet, Robert L. Bronaugh, Daniel A.W. Bucks, Annette L. Bunge, Yie W. Chien, C. Carnot Evans, Gordon L. Flynn, Thomas J. FranzWilliam R. Good, Richard H. Guy, William I. Higuchi, Robert S. Langer, Howard I. Maibach, Jean Paul Marty, Gabriela Nicolau, Esther Patrick, Carl C. Peck, Lynn K. Pershing, Virgil A. Place, Boyd J. Poulsen, Jim E. Riviere, Andre Rougier, Hans Schaefer, Vinod P. Shah, Jane E. Shaw, Jerome P. Skelly, Solomon Sobel, Richard Stoughton, Ronald C. Wester

Research output: Contribution to journalArticlepeer-review

Abstract

This workshop, 'In Vivo Percutaneous Penetration/Absorption' was held in Washington, DC, on May 1-3, 1989. The first workshop in this series, 'In Vitro Percutaneous Penetration', took place in November 1986 (the report of this earlier meeting was published in Pharmaceutical Research, 4 (1987) 265-267). The objectives of the workshop were to review the relevant literature and to address in detail: (1) In vivo percutaneous penetration/absorption methodology; (2) The characteristics of dosage forms designed for application to the skin; (3) Critical factors controlling in vivo drug transport into and across the skin; (4) The use of models in the assessment and evaluation of in vivo percutaneous penetration/absorption; and (5) Bioavailability/bioequivalence considerations for topical drug products. Scientific knowledge and technology are rapidly evolving in the topical and transdermal drug products area. This report focuses on the methodologies available for the measurement of percutaneous penetration in vivo; each scientific approach is discussed briefly followed by advantages and disadvantages of the methodology.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume74
Issue number1
DOIs
Publication statusPublished - 2 Aug 1991

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'In vivo percutaneous penetration/absorption. Sponsored by the American Association of Pharmaceutical Scientist, U.S. Food and Drug Administration, American Academy of Dermatology, Skin Pharmacology Society and the U.S. Army Environmental Hygiene Agency May 1-3, 1989, Washington, DC'. Together they form a unique fingerprint.

Cite this